Total Payments
$599,746
2024 Payments
$142,436
Companies
31
Transactions
849
Medicare Patients
9,678
Medicare Billing
$1.1M
Payment Breakdown by Category
Other$348,755 (58.2%)
Consulting$187,460 (31.3%)
Travel$33,875 (5.6%)
Food & Beverage$26,999 (4.5%)
Research$2,500 (0.4%)
Education$157.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $194,705 | 68 | 32.5% |
| Consulting Fee | $187,460 | 114 | 31.3% |
| Honoraria | $94,700 | 35 | 15.8% |
| Compensation for serving as faculty or as a speaker for a medical education program | $59,350 | 16 | 9.9% |
| Travel and Lodging | $33,875 | 88 | 5.6% |
| Food and Beverage | $26,999 | 524 | 4.5% |
| Unspecified | $2,500 | 1 | 0.4% |
| Education | $157.00 | 3 | 0.0% |
Payments by Type
General
$597,246
848 transactions
Research
$2,500
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | $124,168 | 170 | $0 (2024) |
| Bausch & Lomb Americas Inc. | $94,127 | 97 | $0 (2024) |
| Shire North American Group Inc | $88,350 | 116 | $0 (2019) |
| Oyster Point Pharma, Inc. | $62,960 | 72 | $0 (2024) |
| Allergan, Inc. | $44,584 | 96 | $0 (2022) |
| Johnson & Johnson Surgical Vision, Inc. | $35,822 | 12 | $0 (2024) |
| Eyevance Pharmaceuticals LLC | $34,328 | 38 | $0 (2023) |
| Tarsus Pharmaceuticals, Inc. | $32,472 | 32 | $0 (2024) |
| Thea Pharma Inc. | $19,084 | 8 | $0 (2024) |
| Nordic Pharma, Inc. | $12,179 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $142,436 | 157 | Bausch & Lomb Americas Inc. ($64,004) |
| 2023 | $73,577 | 114 | Bausch & Lomb Americas Inc. ($20,494) |
| 2022 | $47,366 | 85 | Oyster Point Pharma, Inc. ($24,064) |
| 2021 | $41,894 | 84 | Eyevance Pharmaceuticals LLC ($17,387) |
| 2020 | $48,801 | 70 | Sun Pharmaceutical Industries Inc. ($26,477) |
| 2019 | $79,404 | 128 | Sun Pharmaceutical Industries Inc. ($45,043) |
| 2018 | $64,292 | 102 | Shire North American Group Inc ($33,218) |
| 2017 | $101,975 | 109 | Shire North American Group Inc ($45,135) |
All Payment Transactions
849 individual payment records from CMS Open Payments — Page 1 of 34
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $124.63 | General |
| Category: Ophthalmology | ||||||
| 12/30/2024 | Nordic Pharma, Inc. | Lacrifill (Device) | Consulting Fee | Cash or cash equivalent | $12,178.70 | General |
| Category: Opthalmics | ||||||
| 12/23/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $3,400.00 | General |
| Category: Ophthalmology | ||||||
| 12/18/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,575.00 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 12/18/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $30.81 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 12/11/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Food and Beverage | In-kind items and services | $116.93 | General |
| Category: Ophthalmology | ||||||
| 12/10/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Consulting Fee | Cash or cash equivalent | $900.00 | General |
| Category: Dry eyes | ||||||
| 12/08/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug), Xelpros | Food and Beverage | In-kind items and services | $60.92 | General |
| Category: Ophthalmology | ||||||
| 12/07/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $137.50 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 12/06/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $131.89 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 12/05/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $62.27 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 12/05/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $48.64 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 12/04/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $6,800.00 | General |
| Category: Ophthalmology | ||||||
| 12/03/2024 | Bausch & Lomb Americas Inc. | XIPERE (Drug) | Food and Beverage | In-kind items and services | $133.96 | General |
| Category: Ophthalmology | ||||||
| 12/02/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $6.86 | General |
| Category: Ophthalmology | ||||||
| 11/26/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $6,800.00 | General |
| Category: Ophthalmology | ||||||
| 11/25/2024 | Dompe US, Inc. | OXERVATE (Drug) | Food and Beverage | In-kind items and services | $25.29 | General |
| Category: SOLUTION/ DROPS | ||||||
| 11/20/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $21.88 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 11/14/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Travel and Lodging | Cash or cash equivalent | $868.62 | General |
| Category: Ophthalmology | ||||||
| 11/14/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Food and Beverage | In-kind items and services | $105.57 | General |
| Category: Ophthalmology | ||||||
| 11/14/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Travel and Lodging | Cash or cash equivalent | $15.00 | General |
| Category: Ophthalmology | ||||||
| 11/13/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $26.92 | General |
| Category: Dry eyes | ||||||
| 11/12/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,200.00 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 11/12/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $121.84 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 11/11/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $3,200.00 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| MAIC - lifitegrast | Oyster Point Pharma, Inc. | $2,500 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 2,514 | 3,608 | $1.2M | $278,567 |
| 2022 | 19 | 2,580 | 3,653 | $1.3M | $291,934 |
| 2021 | 19 | 2,419 | 3,409 | $1.1M | $266,866 |
| 2020 | 16 | 2,165 | 3,062 | $1.1M | $237,957 |
Total Patients
9,678
Total Services
13,732
Medicare Billing
$1.1M
Procedure Codes
73
All Medicare Procedures & Services
73 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2023 | 130 | 231 | $693,000 | $92,574 | 13.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 577 | 631 | $85,185 | $52,273 | 61.4% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Office | 2023 | 85 | 121 | $134,200 | $29,958 | 22.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 305 | 408 | $40,800 | $24,491 | 60.0% |
| 83861 | Microfluid analysis of tears | Office | 2023 | 273 | 742 | $36,358 | $16,302 | 44.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 139 | 139 | $24,325 | $14,247 | 58.6% |
| 66982 | Complex removal of cataract with insertion of prosthetic lens | Facility | 2023 | 17 | 23 | $92,000 | $12,051 | 13.1% |
| 76519 | Ultrasound scan to determine eye length and lens power | Office | 2023 | 157 | 255 | $34,425 | $8,582 | 24.9% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 156 | 169 | $25,350 | $6,757 | 26.7% |
| 92133 | Imaging of optic nerve | Office | 2023 | 189 | 243 | $20,655 | $5,492 | 26.6% |
| 92134 | Imaging of retina | Office | 2023 | 140 | 154 | $13,090 | $4,261 | 32.6% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 39 | 40 | $5,400 | $2,714 | 50.3% |
| 83516 | Analysis of substance using immunoassay technique, multiple step method | Office | 2023 | 83 | 226 | $11,300 | $2,554 | 22.6% |
| 92250 | Photography of the retina | Office | 2023 | 99 | 99 | $10,395 | $2,468 | 23.7% |
| 92020 | Exam of the internal drainage system of eye | Office | 2023 | 64 | 66 | $4,290 | $1,319 | 30.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 16 | 16 | $1,840 | $1,284 | 69.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 14 | 14 | $1,050 | $571.74 | 54.5% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 11 | 11 | $1,705 | $518.30 | 30.4% |
| 76514 | Ultrasound scan of cornea to determine thickness | Office | 2023 | 20 | 20 | $2,800 | $150.90 | 5.4% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2022 | 139 | 250 | $750,000 | $100,069 | 13.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 588 | 629 | $84,915 | $50,104 | 59.0% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Office | 2022 | 97 | 141 | $155,100 | $34,267 | 22.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 313 | 416 | $41,600 | $24,490 | 58.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 175 | 175 | $30,625 | $17,852 | 58.3% |
| 83861 | Microfluid analysis of tears | Office | 2022 | 258 | 699 | $34,251 | $15,518 | 45.3% |
About Dr. Darrell White, MD
Dr. Darrell White, MD is a Ophthalmology healthcare provider based in Westlake, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/29/2006. The National Provider Identifier (NPI) number assigned to this provider is 1417918517.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Darrell White, MD has received a total of $599,746 in payments from pharmaceutical and medical device companies, with $142,436 received in 2024. These payments were reported across 849 transactions from 31 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($194,705).
As a Medicare-enrolled provider, White has provided services to 9,678 Medicare beneficiaries, totaling 13,732 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 73 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Location Westlake, OH
- Active Since 03/29/2006
- Last Updated 07/12/2007
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1417918517
Products in Payments
- XIIDRA (Drug) $99,475
- MIEBO (Drug) $72,202
- TYRVAYA (Drug) $60,460
- CEQUA (Drug) $46,992
- Cequa (Drug) $28,975
- BROMSITE (Drug) $24,517
- XDEMVY (Drug) $18,920
- RESTASIS (Drug) $18,691
- Flarex (Drug) $15,755
- Lacrifill (Device) $12,179
- Zerviate (Drug) $10,705
- BromSite (bromfenac ophthalmic solution) 0.075% (Drug) $9,520
- Bromsite (Drug) $8,796
- Tobradex ST (Drug) $7,867
- TEARLAB OSMOLARITY SYSTEM (Device) $7,781
- OMIDRIA (Drug) $7,159
- RESTASIS MULTIDOSE (Drug) $5,949
- EYSUVIS (Drug) $5,591
- CEQUA (cyclosporine ophthalmic solution) 0.09% (Drug) $5,131
- AZASITE (Drug) $3,750
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Westlake
Mary Lavery, Md, MD
Ophthalmology — Payments: $4,837
Ophthalmology $4,837
Dr. Robert Stern, M.d, M.D
Ophthalmology — Payments: $1,569
Ophthalmology $1,569
Elisa Bala, Md, Msc, MD, MSC
Ophthalmology — Payments: $1,299
Ophthalmology $1,299
George Rozakis, Md, MD
Ophthalmology — Payments: $190.84
Ophthalmology $190.84
Charles Kutina, Md, MD
Ophthalmology
Ophthalmology